enGene Therapeutics Inc.: Form 10-K/A for the period ended Oct 31, 2024
Filed with the SEC on Feb 20, 2025 and accepted by EDGAR at Feb 20, 2025, 16:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-25-024221. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.